MILAN and NEW YORK, Jan. 27, 2026 (GLOBE NEWSWIRE) -- In response to evolving market dynamics and strategic opportunities, Genenta Science S.p.A (Nasdaq: GNTA) is embarking on a strategic ...
SAN FRANCISCO--(BUSINESS WIRE)--Biotechnology is set for significant transformation in 2025 with an incoming political administration, rapid scientific advancements, and the convergence of technology ...
Investor's Business Daily on MSN
China biotech lights up. US stocks prepare for a new powerhouse.
U.S.-based biotech stocks are closely watching the China's rapid advance into the biotech field. Will they withstand the rivalry?
Trinity Biotech has now begun manufacturing under this new model, marking a critical milestone in the Company’s transformation strategy. The strategic shift is expected to: Expand gross margins. Free ...
DUBLIN, June 24, 2025 (GLOBE NEWSWIRE) -- Trinity Biotech plc (TRIB), a commercial-stage biotechnology company focused on human diagnostics and diabetes management solutions, including wearable ...
This local regulatory approval builds on Trinity Biotech’s WHO approval for Uni-Gold™ HIV in November 2025, which authorised the Company’s upstream manufacturing approach and served as the technical ...
This reflects India’s transition from being a late entrant to becoming an early mover in emerging technologies,” he said.
DUBLIN, Aug. 20, 2025 (GLOBE NEWSWIRE) -- Trinity Biotech plc (TRIB), a commercial-stage biotechnology company focused on human diagnostics and diabetes management solutions, including wearable ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results